kinetic study on the reactions of platinum drugs with glutathione

kinetic study on the reactions of platinum drugs with glutathione Catalytic Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium-Flavin Catalyst Chemical Imaging of Platinum-Based Drugs – Glutathione responsive nanomedicine leverages tumor

Name: kinetic study on the reactions of platinum drugs with glutathione Catalytic Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium-Flavin Catalyst Chemical Imaging of Platinum-Based Drugs – Glutathione responsive nanomedicine leverages tumor
Brand: www.djecji-vrtic-kucica.hr
SKU: 71919257026
Price: 29.22 USD
Availability: InStock
Rating: 4.8199000000000005 (29 reviews)

Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link Combination strategies of platinum based drugs (cisplatin or Download Scientific Diagram Platinum drug mechanism of action. Left: The established and well known Download Scientific Diagram A cisplatin based platinum(IV) prodrug containing a glutathione s transferase inhibitor to reverse cisplatin resistance in non small cell lung cancer ScienceDirect

SKU: 71919257026 · From www.djecji-vrtic-kucica.hr

4.8

USD29.22 USD56.22

Pay in 4 interest-free payments of $7.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Adding any hepatotoxic supplement to this already watchful protocol is a decision that requires explicit physician sign-off

However, patients with adrenocortical cancer (ACC), liver hepatocellular carcinoma (LIHC), and endometrial carcinoma (UCEC) tend to have a poorer prognosis when CRGs are highly expressed